CANC vs. MNTL ETF Comparison
Comparison of Tema Oncology ETF (CANC) to Tema Neuroscience and Mental Health ETF (MNTL)
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$27.48
Average Daily Volume
536
Number of Holdings
*
7
* may have additional holdings in another (foreign) market
MNTL
Tema Neuroscience and Mental Health ETF
MNTL Description
Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies. A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health. The fund is non-diversified.Grade (RS Rating)
Last Trade
$24.96
Average Daily Volume
364
Number of Holdings
*
10
* may have additional holdings in another (foreign) market
Performance
Period | CANC | MNTL |
---|---|---|
30 Days | 1.66% | -1.76% |
60 Days | -2.41% | -5.40% |
90 Days | 1.40% | -2.45% |
12 Months |
CANC: Top Represented Industries & Keywords
Industries:
Drug Manufacturers - Major
Biotechnology
Diagnostics & Research
Keywords:
Medicine
S&P 500
Antibiotics
Biopharmaceutical
Biotechnology
Infectious Diseases
Inflammation
Nasdaq 100
Ophthalmology
Animal Health
Cancer
Cardiovascular Disease
Clinical Research
Colorectal Cancer
Lab Testing
Life Sciences
Macular Degeneration
Medication
Molecular Diagnostics
Respiratory Diseases
MNTL: Top Represented Industries & Keywords